PCOS, or polycystic ovarian syndrome, is one of the most common female endocrine disorders, affecting 6-15 percent of women. PCOS causes hormonal imbalances and metabolism issues in women, which can have an impact on their overall health and attractiveness. Although insulin resistance is not invariably present, androgen excess and insulin resistance are now acknowledged to be responsible for much of the phenotypic appearance. It’s marked by an irregular menstrual cycle and acne, and it’s linked to type 2 diabetes and cardiovascular disease. A prospective window of opportunity to avoid the risk of related consequences exists when PCOS is managed effectively. The treatment aims to address (IR), hyperandrogenism’s consequences, irregular menstruation, and infertility in general. The genesis, pathophysiology, diagnosis, and therapy of polycystic ovarian syndrome are the focus of this review paper.

Author (s) Details

Dr. C. Muhas
Department of Pharmacy Practice, KTN College of Pharmacy, Chalavara, Palakkad, Kerala, India.

Dr. K. M. Nishad
Department of Pharmaceutics, Jamia Salafiya Pharmacy College, Pulikkal, Kerala, India.

Prof (Dr), P. P. Naseef
Department of Pharmaceutics, Moulana College of Pharmacy, Perintalmanna, Kerala, India.

K. Abdul Vajid

Department of Pharmaceutics, Moulana College of Pharmacy, Perintalmanna, Kerala, India.

View Book :- https://stm.bookpi.org/TIPR-V6/article/view/1702

Leave a Reply

Your email address will not be published. Required fields are marked *